Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Actinic (Solar) Keratosis - Overview
Actinic (Solar) Keratosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Actinic (Solar) Keratosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Actinic (Solar) Keratosis - Companies Involved in Therapeutics Development
AmDerma Pharmaceuticals LLC
Athenex Inc
G&E Corp
Henderson Morley Plc (Ictive)
Laboratories Ojer Pharma SL
MedC Biopharma Ltd
nology LLC
Neonc Technologies Inc
Oncology Research Intertiol Ltd
Singh Biotechnology LLC
Sol-Gel Technologies Ltd
Vidac Pharma Ltd
Actinic (Solar) Keratosis - Drug Profiles
(digoxin + furosemide) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AM-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
imiquimod SR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDC-2040 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NEO-412 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ORIL-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SBT-300 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SGT-210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SOR-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SRT-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tirbanibulin mesylate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tuvatexib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Actinic (Solar) Keratosis - Dormant Projects
Actinic (Solar) Keratosis - Discontinued Products
Actinic (Solar) Keratosis - Product Development Milestones
Featured News & Press Releases
Mar 09, 2020: Athenex announces FDA acceptance for filing of U.S. NDA for tirbanibulin ointment in actinic keratosis
Mar 02, 2020: Athenex’s partner Almirall announces EMA acceptance for filing of Marketing Authorization Application (MAA) for tirbanibulin ointment in actinic keratosis
Oct 28, 2019: Athenex announces progress update from partner Almirall on Tirbanibulin Ointment
Mar 04, 2019: Athenex announces positive topline results from two phase III studies of KX2-391 ointment 1% featured in late breaker program at the 2019 American Academy of Dermatology Annual Meeting
Feb 25, 2019: Athenex to host conference call with key opinion leader following oral presentation of phase III results of KX2-391 ointment in the treatment of actinic keratosis at the American Academy of Dermatology Annual Meeting
Feb 04, 2019: Athenex announces late-breaking oral presentation of KX2-391 ointment in two phase III studies at the American Academy of Dermatology Annual Meeting
Dec 16, 2018: Vidac Pharma announce publication of peer reviewed article on VDA-1102 mechanism of action
Sep 18, 2018: DFB Soria completes a phase 2 clinical Trial of submicron particle Paclitaxel anhydrous ointment for actinic keratosis
Jul 26, 2018: Almirall announces that both phase III trials of KX2-391 for actinic keratosis achieved primary endpoint
Jul 26, 2018: Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints
Jul 10, 2018: Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis
Feb 20, 2018: Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis in the American Academy of Dermatology Meeting
Feb 14, 2018: Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis
Dec 18, 2017: nOlogy Announces First Patient Enrolled in a Pancreatic Cancer Phase II Clinical Trial of noPac Adding to Trials in Prostate and Ovarian Cancers
Nov 28, 2017: Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Actinic (Solar) Keratosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Actinic (Solar) Keratosis, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Actinic (Solar) Keratosis - Pipeline by AmDerma Pharmaceuticals LLC, H2 2020
Actinic (Solar) Keratosis - Pipeline by Athenex Inc, H2 2020
Actinic (Solar) Keratosis - Pipeline by G&E Corp, H2 2020
Actinic (Solar) Keratosis - Pipeline by Henderson Morley Plc (Inactive), H2 2020
Actinic (Solar) Keratosis - Pipeline by Laboratories Ojer Pharma SL, H2 2020
Actinic (Solar) Keratosis - Pipeline by MedC Biopharma Ltd, H2 2020
Actinic (Solar) Keratosis - Pipeline by Nanology LLC, H2 2020
Actinic (Solar) Keratosis - Pipeline by Neonc Technologies Inc, H2 2020
Actinic (Solar) Keratosis - Pipeline by Oncology Research International Ltd, H2 2020
Actinic (Solar) Keratosis - Pipeline by Singh Biotechnology LLC, H2 2020
Actinic (Solar) Keratosis - Pipeline by Sol-Gel Technologies Ltd, H2 2020
Actinic (Solar) Keratosis - Pipeline by Vidac Pharma Ltd, H2 2020
Actinic (Solar) Keratosis - Dormant Projects, H2 2020
Actinic (Solar) Keratosis - Dormant Projects, H2 2020 (Contd..1), H2 2020
Actinic (Solar) Keratosis - Dormant Projects, H2 2020 (Contd..2), H2 2020
Actinic (Solar) Keratosis - Discontinued Products, H2 2020